Corza Medical Inc

Corza Medical is a global medical technology company with $500M+ in annual revenue, 3,000+ employees, and operations in 80+ countries. The company manufactures and distributes surgical consumables, wound closure solutions, biosurgery products, biomedical textiles, and ophthalmic instruments through multiple product lines and acquired brands. Primary product portfolios include: Quill barbed sutures for wound closure; TachoSil and TachoComb hemostasis/sealing matrices for surgical hemostasis; Sharpoint sutures and surgical knives; Katena ophthalmic microsurgical instruments and accessories; Pearsalls biomedical textiles for OEM partners; and specialty suture products (Express Gut, Look, Blink). The company operates manufacturing facilities across seven global locations including the United States, Europe, China, and Mexico. Corza Medical serves hospitals, surgical centers, and healthcare providers across general surgery, ophthalmology, wound closure, and biosurgery specialties. The company emphasizes regulatory compliance, quality assurance, and medical education support. It maintains headquarters in Boulder, CO (Global), Zurich, Switzerland (EMEA), and Shanghai, China, with additional operational facilities in Michigan, Missouri, Pennsylvania, Germany, the United Kingdom, and Mexico. Corza Medical was recognized in the 2024 MedTech Big 100 list and received the 2024 Global Excellence Award for innovative wound closure solutions.